nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—PGD—Methotrexate—testicular cancer	0.205	0.273	CbGbCtD
Furosemide—SLC22A5—Dactinomycin—testicular cancer	0.116	0.154	CbGbCtD
Furosemide—SLC22A11—Methotrexate—testicular cancer	0.0608	0.0809	CbGbCtD
Furosemide—ABCC2—Carboplatin—testicular cancer	0.0606	0.0808	CbGbCtD
Furosemide—ABCC2—Vinblastine—testicular cancer	0.0565	0.0753	CbGbCtD
Furosemide—ABCC2—Cisplatin—testicular cancer	0.0518	0.069	CbGbCtD
Furosemide—ABCC2—Etoposide—testicular cancer	0.0509	0.0678	CbGbCtD
Furosemide—SLC22A8—Methotrexate—testicular cancer	0.0353	0.0471	CbGbCtD
Furosemide—ABCC2—Doxorubicin—testicular cancer	0.0347	0.0463	CbGbCtD
Furosemide—ABCC2—Methotrexate—testicular cancer	0.0336	0.0448	CbGbCtD
Furosemide—SLC22A6—Methotrexate—testicular cancer	0.0246	0.0328	CbGbCtD
Furosemide—ALB—Methotrexate—testicular cancer	0.021	0.0279	CbGbCtD
Furosemide—CA14—seminal vesicle—testicular cancer	0.00224	0.0809	CbGeAlD
Furosemide—SLCO2A1—seminal vesicle—testicular cancer	0.00185	0.067	CbGeAlD
Furosemide—PGD—seminal vesicle—testicular cancer	0.00165	0.0598	CbGeAlD
Furosemide—CA9—testis—testicular cancer	0.00123	0.0444	CbGeAlD
Furosemide—PGD—gonad—testicular cancer	0.00119	0.0432	CbGeAlD
Furosemide—CA5B—gonad—testicular cancer	0.00113	0.0409	CbGeAlD
Furosemide—SLCO2A1—female gonad—testicular cancer	0.00109	0.0394	CbGeAlD
Furosemide—CA4—seminal vesicle—testicular cancer	0.00108	0.0391	CbGeAlD
Furosemide—SLC12A1—testis—testicular cancer	0.00105	0.0378	CbGeAlD
Furosemide—PGD—female gonad—testicular cancer	0.00097	0.0351	CbGeAlD
Furosemide—SLCO2A1—testis—testicular cancer	0.000965	0.0349	CbGeAlD
Furosemide—CA2—embryo—testicular cancer	0.000954	0.0345	CbGeAlD
Furosemide—CA2—seminal vesicle—testicular cancer	0.000896	0.0324	CbGeAlD
Furosemide—SLC22A5—seminal vesicle—testicular cancer	0.000881	0.0319	CbGeAlD
Furosemide—PGD—testis—testicular cancer	0.00086	0.0311	CbGeAlD
Furosemide—CA5B—testis—testicular cancer	0.000815	0.0295	CbGeAlD
Furosemide—SLCO2A1—lymph node—testicular cancer	0.0007	0.0253	CbGeAlD
Furosemide—CA4—female gonad—testicular cancer	0.000634	0.0229	CbGeAlD
Furosemide—ALB—testis—testicular cancer	0.000632	0.0229	CbGeAlD
Furosemide—PGD—lymph node—testicular cancer	0.000624	0.0226	CbGeAlD
Furosemide—ABCC2—testis—testicular cancer	0.000592	0.0214	CbGeAlD
Furosemide—CA5B—lymph node—testicular cancer	0.000591	0.0214	CbGeAlD
Furosemide—CA4—testis—testicular cancer	0.000563	0.0203	CbGeAlD
Furosemide—CA2—female gonad—testicular cancer	0.000526	0.019	CbGeAlD
Furosemide—CA1—lymph node—testicular cancer	0.000522	0.0189	CbGeAlD
Furosemide—SLC22A5—female gonad—testicular cancer	0.000517	0.0187	CbGeAlD
Furosemide—CA2—testis—testicular cancer	0.000466	0.0169	CbGeAlD
Furosemide—SLC22A5—testis—testicular cancer	0.000459	0.0166	CbGeAlD
Furosemide—ALB—lymph node—testicular cancer	0.000458	0.0166	CbGeAlD
Furosemide—ABCC2—lymph node—testicular cancer	0.000429	0.0155	CbGeAlD
Furosemide—CA4—lymph node—testicular cancer	0.000408	0.0147	CbGeAlD
Furosemide—CA2—lymph node—testicular cancer	0.000338	0.0122	CbGeAlD
Furosemide—SLC22A5—lymph node—testicular cancer	0.000333	0.012	CbGeAlD
Furosemide—Confusional state—Etoposide—testicular cancer	0.000274	0.00124	CcSEcCtD
Furosemide—Muscular weakness—Epirubicin—testicular cancer	0.000274	0.00124	CcSEcCtD
Furosemide—Urticaria—Ifosfamide—testicular cancer	0.000274	0.00124	CcSEcCtD
Furosemide—Abdominal pain—Ifosfamide—testicular cancer	0.000272	0.00123	CcSEcCtD
Furosemide—Body temperature increased—Ifosfamide—testicular cancer	0.000272	0.00123	CcSEcCtD
Furosemide—Anaphylactic shock—Etoposide—testicular cancer	0.000272	0.00123	CcSEcCtD
Furosemide—Abdominal distension—Epirubicin—testicular cancer	0.00027	0.00122	CcSEcCtD
Furosemide—Asthenia—Dactinomycin—testicular cancer	0.00027	0.00122	CcSEcCtD
Furosemide—Blood creatinine increased—Doxorubicin—testicular cancer	0.000269	0.00121	CcSEcCtD
Furosemide—Dehydration—Doxorubicin—testicular cancer	0.000267	0.00121	CcSEcCtD
Furosemide—Paraesthesia—Cisplatin—testicular cancer	0.000267	0.0012	CcSEcCtD
Furosemide—Thrombocytopenia—Etoposide—testicular cancer	0.000266	0.0012	CcSEcCtD
Furosemide—Eosinophilia—Epirubicin—testicular cancer	0.000266	0.0012	CcSEcCtD
Furosemide—Skin disorder—Etoposide—testicular cancer	0.000264	0.00119	CcSEcCtD
Furosemide—Hyperhidrosis—Etoposide—testicular cancer	0.000263	0.00119	CcSEcCtD
Furosemide—Pancreatitis—Epirubicin—testicular cancer	0.000263	0.00119	CcSEcCtD
Furosemide—Orthostatic hypotension—Doxorubicin—testicular cancer	0.000262	0.00118	CcSEcCtD
Furosemide—Photosensitivity reaction—Methotrexate—testicular cancer	0.000262	0.00118	CcSEcCtD
Furosemide—Hypokalaemia—Doxorubicin—testicular cancer	0.000261	0.00118	CcSEcCtD
Furosemide—Anorexia—Etoposide—testicular cancer	0.000259	0.00117	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.000259	0.00117	CcSEcCtD
Furosemide—Decreased appetite—Cisplatin—testicular cancer	0.000258	0.00117	CcSEcCtD
Furosemide—Diarrhoea—Dactinomycin—testicular cancer	0.000257	0.00116	CcSEcCtD
Furosemide—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000256	0.00116	CcSEcCtD
Furosemide—Vomiting—Bleomycin—testicular cancer	0.000256	0.00116	CcSEcCtD
Furosemide—Drowsiness—Methotrexate—testicular cancer	0.000256	0.00115	CcSEcCtD
Furosemide—Hypotension—Etoposide—testicular cancer	0.000254	0.00115	CcSEcCtD
Furosemide—Rash—Bleomycin—testicular cancer	0.000254	0.00115	CcSEcCtD
Furosemide—Pain—Cisplatin—testicular cancer	0.000254	0.00115	CcSEcCtD
Furosemide—Dermatitis—Bleomycin—testicular cancer	0.000254	0.00115	CcSEcCtD
Furosemide—Hypersensitivity—Ifosfamide—testicular cancer	0.000254	0.00115	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000253	0.00114	CcSEcCtD
Furosemide—Muscular weakness—Doxorubicin—testicular cancer	0.000253	0.00114	CcSEcCtD
Furosemide—Renal failure—Methotrexate—testicular cancer	0.000251	0.00113	CcSEcCtD
Furosemide—Abdominal distension—Doxorubicin—testicular cancer	0.00025	0.00113	CcSEcCtD
Furosemide—Pollakiuria—Epirubicin—testicular cancer	0.000248	0.00112	CcSEcCtD
Furosemide—Asthenia—Ifosfamide—testicular cancer	0.000247	0.00112	CcSEcCtD
Furosemide—Eosinophilia—Doxorubicin—testicular cancer	0.000246	0.00111	CcSEcCtD
Furosemide—Sweating—Methotrexate—testicular cancer	0.000245	0.00111	CcSEcCtD
Furosemide—Photosensitivity reaction—Epirubicin—testicular cancer	0.000245	0.00111	CcSEcCtD
Furosemide—Feeling abnormal—Cisplatin—testicular cancer	0.000245	0.00111	CcSEcCtD
Furosemide—Paraesthesia—Etoposide—testicular cancer	0.000244	0.0011	CcSEcCtD
Furosemide—Pruritus—Ifosfamide—testicular cancer	0.000244	0.0011	CcSEcCtD
Furosemide—Pancreatitis—Doxorubicin—testicular cancer	0.000243	0.0011	CcSEcCtD
Furosemide—Hyperglycaemia—Epirubicin—testicular cancer	0.000242	0.00109	CcSEcCtD
Furosemide—Somnolence—Etoposide—testicular cancer	0.000242	0.00109	CcSEcCtD
Furosemide—Hepatobiliary disease—Methotrexate—testicular cancer	0.000242	0.00109	CcSEcCtD
Furosemide—Nausea—Bleomycin—testicular cancer	0.00024	0.00108	CcSEcCtD
Furosemide—Drowsiness—Epirubicin—testicular cancer	0.000239	0.00108	CcSEcCtD
Furosemide—Vomiting—Dactinomycin—testicular cancer	0.000239	0.00108	CcSEcCtD
Furosemide—Agranulocytosis—Methotrexate—testicular cancer	0.000239	0.00108	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000237	0.00107	CcSEcCtD
Furosemide—Rash—Dactinomycin—testicular cancer	0.000237	0.00107	CcSEcCtD
Furosemide—Decreased appetite—Etoposide—testicular cancer	0.000237	0.00107	CcSEcCtD
Furosemide—Diarrhoea—Ifosfamide—testicular cancer	0.000236	0.00106	CcSEcCtD
Furosemide—Renal failure—Epirubicin—testicular cancer	0.000235	0.00106	CcSEcCtD
Furosemide—Gastrointestinal disorder—Etoposide—testicular cancer	0.000235	0.00106	CcSEcCtD
Furosemide—Body temperature increased—Cisplatin—testicular cancer	0.000235	0.00106	CcSEcCtD
Furosemide—Fatigue—Etoposide—testicular cancer	0.000235	0.00106	CcSEcCtD
Furosemide—Pain—Etoposide—testicular cancer	0.000233	0.00105	CcSEcCtD
Furosemide—Constipation—Etoposide—testicular cancer	0.000233	0.00105	CcSEcCtD
Furosemide—Sweating—Epirubicin—testicular cancer	0.000229	0.00104	CcSEcCtD
Furosemide—Pollakiuria—Doxorubicin—testicular cancer	0.000229	0.00104	CcSEcCtD
Furosemide—Dizziness—Ifosfamide—testicular cancer	0.000228	0.00103	CcSEcCtD
Furosemide—Urinary tract disorder—Methotrexate—testicular cancer	0.000227	0.00102	CcSEcCtD
Furosemide—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000227	0.00102	CcSEcCtD
Furosemide—Hepatobiliary disease—Epirubicin—testicular cancer	0.000226	0.00102	CcSEcCtD
Furosemide—Urethral disorder—Methotrexate—testicular cancer	0.000225	0.00102	CcSEcCtD
Furosemide—Feeling abnormal—Etoposide—testicular cancer	0.000224	0.00101	CcSEcCtD
Furosemide—Hyperglycaemia—Doxorubicin—testicular cancer	0.000224	0.00101	CcSEcCtD
Furosemide—Nausea—Dactinomycin—testicular cancer	0.000223	0.00101	CcSEcCtD
Furosemide—Agranulocytosis—Epirubicin—testicular cancer	0.000223	0.00101	CcSEcCtD
Furosemide—Gastrointestinal pain—Etoposide—testicular cancer	0.000223	0.001	CcSEcCtD
Furosemide—Drowsiness—Doxorubicin—testicular cancer	0.000221	0.000999	CcSEcCtD
Furosemide—Visual impairment—Methotrexate—testicular cancer	0.000221	0.000998	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000219	0.000991	CcSEcCtD
Furosemide—Vomiting—Ifosfamide—testicular cancer	0.000219	0.000989	CcSEcCtD
Furosemide—Hypersensitivity—Cisplatin—testicular cancer	0.000219	0.000988	CcSEcCtD
Furosemide—Renal failure—Doxorubicin—testicular cancer	0.000218	0.000982	CcSEcCtD
Furosemide—Rash—Ifosfamide—testicular cancer	0.000217	0.000981	CcSEcCtD
Furosemide—Dermatitis—Ifosfamide—testicular cancer	0.000217	0.00098	CcSEcCtD
Furosemide—Erythema multiforme—Methotrexate—testicular cancer	0.000217	0.000979	CcSEcCtD
Furosemide—Urticaria—Etoposide—testicular cancer	0.000216	0.000976	CcSEcCtD
Furosemide—Abdominal pain—Etoposide—testicular cancer	0.000215	0.000971	CcSEcCtD
Furosemide—Body temperature increased—Etoposide—testicular cancer	0.000215	0.000971	CcSEcCtD
Furosemide—Eye disorder—Methotrexate—testicular cancer	0.000214	0.000968	CcSEcCtD
Furosemide—Tinnitus—Methotrexate—testicular cancer	0.000214	0.000966	CcSEcCtD
Furosemide—Asthenia—Cisplatin—testicular cancer	0.000213	0.000962	CcSEcCtD
Furosemide—Sweating—Doxorubicin—testicular cancer	0.000212	0.000958	CcSEcCtD
Furosemide—Urinary tract disorder—Epirubicin—testicular cancer	0.000212	0.000957	CcSEcCtD
Furosemide—Urethral disorder—Epirubicin—testicular cancer	0.000211	0.00095	CcSEcCtD
Furosemide—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000209	0.000945	CcSEcCtD
Furosemide—Angiopathy—Methotrexate—testicular cancer	0.000208	0.00094	CcSEcCtD
Furosemide—Immune system disorder—Methotrexate—testicular cancer	0.000207	0.000936	CcSEcCtD
Furosemide—Visual impairment—Epirubicin—testicular cancer	0.000207	0.000934	CcSEcCtD
Furosemide—Agranulocytosis—Doxorubicin—testicular cancer	0.000207	0.000932	CcSEcCtD
Furosemide—Nausea—Ifosfamide—testicular cancer	0.000205	0.000924	CcSEcCtD
Furosemide—Diarrhoea—Cisplatin—testicular cancer	0.000203	0.000918	CcSEcCtD
Furosemide—Erythema multiforme—Epirubicin—testicular cancer	0.000203	0.000917	CcSEcCtD
Furosemide—Eye disorder—Epirubicin—testicular cancer	0.000201	0.000906	CcSEcCtD
Furosemide—Hypersensitivity—Etoposide—testicular cancer	0.000201	0.000905	CcSEcCtD
Furosemide—Tinnitus—Epirubicin—testicular cancer	0.0002	0.000904	CcSEcCtD
Furosemide—Malnutrition—Methotrexate—testicular cancer	0.0002	0.000902	CcSEcCtD
Furosemide—Erythema—Methotrexate—testicular cancer	0.0002	0.000902	CcSEcCtD
Furosemide—Urinary tract disorder—Doxorubicin—testicular cancer	0.000196	0.000886	CcSEcCtD
Furosemide—Dysgeusia—Methotrexate—testicular cancer	0.000196	0.000883	CcSEcCtD
Furosemide—Asthenia—Etoposide—testicular cancer	0.000195	0.000882	CcSEcCtD
Furosemide—Angiopathy—Epirubicin—testicular cancer	0.000195	0.00088	CcSEcCtD
Furosemide—Urethral disorder—Doxorubicin—testicular cancer	0.000195	0.000879	CcSEcCtD
Furosemide—Immune system disorder—Epirubicin—testicular cancer	0.000194	0.000876	CcSEcCtD
Furosemide—Pruritus—Etoposide—testicular cancer	0.000193	0.000869	CcSEcCtD
Furosemide—Arrhythmia—Epirubicin—testicular cancer	0.000192	0.000866	CcSEcCtD
Furosemide—Visual impairment—Doxorubicin—testicular cancer	0.000191	0.000864	CcSEcCtD
Furosemide—Vomiting—Cisplatin—testicular cancer	0.000189	0.000853	CcSEcCtD
Furosemide—Vision blurred—Methotrexate—testicular cancer	0.000188	0.00085	CcSEcCtD
Furosemide—Erythema multiforme—Doxorubicin—testicular cancer	0.000188	0.000848	CcSEcCtD
Furosemide—Rash—Cisplatin—testicular cancer	0.000187	0.000846	CcSEcCtD
Furosemide—Dermatitis—Cisplatin—testicular cancer	0.000187	0.000845	CcSEcCtD
Furosemide—Erythema—Epirubicin—testicular cancer	0.000187	0.000844	CcSEcCtD
Furosemide—Malnutrition—Epirubicin—testicular cancer	0.000187	0.000844	CcSEcCtD
Furosemide—Diarrhoea—Etoposide—testicular cancer	0.000186	0.000841	CcSEcCtD
Furosemide—Eye disorder—Doxorubicin—testicular cancer	0.000186	0.000838	CcSEcCtD
Furosemide—Tinnitus—Doxorubicin—testicular cancer	0.000185	0.000836	CcSEcCtD
Furosemide—Anaemia—Methotrexate—testicular cancer	0.000185	0.000833	CcSEcCtD
Furosemide—Flatulence—Epirubicin—testicular cancer	0.000184	0.000832	CcSEcCtD
Furosemide—Dysgeusia—Epirubicin—testicular cancer	0.000183	0.000826	CcSEcCtD
Furosemide—Angiopathy—Doxorubicin—testicular cancer	0.00018	0.000814	CcSEcCtD
Furosemide—Dizziness—Etoposide—testicular cancer	0.00018	0.000812	CcSEcCtD
Furosemide—Muscle spasms—Epirubicin—testicular cancer	0.00018	0.000811	CcSEcCtD
Furosemide—Immune system disorder—Doxorubicin—testicular cancer	0.000179	0.00081	CcSEcCtD
Furosemide—Vertigo—Methotrexate—testicular cancer	0.000179	0.00081	CcSEcCtD
Furosemide—Leukopenia—Methotrexate—testicular cancer	0.000179	0.000807	CcSEcCtD
Furosemide—Arrhythmia—Doxorubicin—testicular cancer	0.000178	0.000801	CcSEcCtD
Furosemide—Nausea—Cisplatin—testicular cancer	0.000176	0.000797	CcSEcCtD
Furosemide—Vision blurred—Epirubicin—testicular cancer	0.000176	0.000795	CcSEcCtD
Furosemide—Vomiting—Etoposide—testicular cancer	0.000173	0.000781	CcSEcCtD
Furosemide—Malnutrition—Doxorubicin—testicular cancer	0.000173	0.000781	CcSEcCtD
Furosemide—Erythema—Doxorubicin—testicular cancer	0.000173	0.000781	CcSEcCtD
Furosemide—Anaemia—Epirubicin—testicular cancer	0.000173	0.00078	CcSEcCtD
Furosemide—Agitation—Epirubicin—testicular cancer	0.000172	0.000776	CcSEcCtD
Furosemide—Rash—Etoposide—testicular cancer	0.000172	0.000775	CcSEcCtD
Furosemide—Dermatitis—Etoposide—testicular cancer	0.000171	0.000774	CcSEcCtD
Furosemide—Headache—Etoposide—testicular cancer	0.000171	0.00077	CcSEcCtD
Furosemide—Flatulence—Doxorubicin—testicular cancer	0.00017	0.000769	CcSEcCtD
Furosemide—Dysgeusia—Doxorubicin—testicular cancer	0.000169	0.000765	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000169	0.000762	CcSEcCtD
Furosemide—Vertigo—Epirubicin—testicular cancer	0.000168	0.000758	CcSEcCtD
Furosemide—Leukopenia—Epirubicin—testicular cancer	0.000167	0.000755	CcSEcCtD
Furosemide—Muscle spasms—Doxorubicin—testicular cancer	0.000166	0.000751	CcSEcCtD
Furosemide—Confusional state—Methotrexate—testicular cancer	0.000164	0.000742	CcSEcCtD
Furosemide—Anaphylactic shock—Methotrexate—testicular cancer	0.000163	0.000736	CcSEcCtD
Furosemide—Vision blurred—Doxorubicin—testicular cancer	0.000163	0.000736	CcSEcCtD
Furosemide—Nausea—Etoposide—testicular cancer	0.000162	0.00073	CcSEcCtD
Furosemide—Nervous system disorder—Methotrexate—testicular cancer	0.00016	0.000722	CcSEcCtD
Furosemide—Anaemia—Doxorubicin—testicular cancer	0.00016	0.000722	CcSEcCtD
Furosemide—Thrombocytopenia—Methotrexate—testicular cancer	0.00016	0.000721	CcSEcCtD
Furosemide—Agitation—Doxorubicin—testicular cancer	0.000159	0.000718	CcSEcCtD
Furosemide—Skin disorder—Methotrexate—testicular cancer	0.000158	0.000715	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000158	0.000714	CcSEcCtD
Furosemide—Hyperhidrosis—Methotrexate—testicular cancer	0.000158	0.000711	CcSEcCtD
Furosemide—Dry mouth—Epirubicin—testicular cancer	0.000156	0.000703	CcSEcCtD
Furosemide—Vertigo—Doxorubicin—testicular cancer	0.000155	0.000702	CcSEcCtD
Furosemide—Anorexia—Methotrexate—testicular cancer	0.000155	0.000702	CcSEcCtD
Furosemide—Leukopenia—Doxorubicin—testicular cancer	0.000155	0.000699	CcSEcCtD
Furosemide—Confusional state—Epirubicin—testicular cancer	0.000154	0.000694	CcSEcCtD
Furosemide—Anaphylactic shock—Epirubicin—testicular cancer	0.000153	0.000689	CcSEcCtD
Furosemide—Hypotension—Methotrexate—testicular cancer	0.000152	0.000688	CcSEcCtD
Furosemide—Shock—Epirubicin—testicular cancer	0.00015	0.000678	CcSEcCtD
Furosemide—Nervous system disorder—Epirubicin—testicular cancer	0.00015	0.000675	CcSEcCtD
Furosemide—Thrombocytopenia—Epirubicin—testicular cancer	0.000149	0.000674	CcSEcCtD
Furosemide—Skin disorder—Epirubicin—testicular cancer	0.000148	0.000669	CcSEcCtD
Furosemide—Hyperhidrosis—Epirubicin—testicular cancer	0.000147	0.000666	CcSEcCtD
Furosemide—Paraesthesia—Methotrexate—testicular cancer	0.000146	0.000661	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000146	0.00066	CcSEcCtD
Furosemide—Anorexia—Epirubicin—testicular cancer	0.000145	0.000657	CcSEcCtD
Furosemide—Somnolence—Methotrexate—testicular cancer	0.000145	0.000654	CcSEcCtD
Furosemide—Dry mouth—Doxorubicin—testicular cancer	0.000144	0.00065	CcSEcCtD
Furosemide—Hypotension—Epirubicin—testicular cancer	0.000143	0.000644	CcSEcCtD
Furosemide—Confusional state—Doxorubicin—testicular cancer	0.000142	0.000643	CcSEcCtD
Furosemide—Decreased appetite—Methotrexate—testicular cancer	0.000142	0.00064	CcSEcCtD
Furosemide—Anaphylactic shock—Doxorubicin—testicular cancer	0.000141	0.000637	CcSEcCtD
Furosemide—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000141	0.000635	CcSEcCtD
Furosemide—Fatigue—Methotrexate—testicular cancer	0.000141	0.000635	CcSEcCtD
Furosemide—Pain—Methotrexate—testicular cancer	0.000139	0.000629	CcSEcCtD
Furosemide—Shock—Doxorubicin—testicular cancer	0.000139	0.000627	CcSEcCtD
Furosemide—Nervous system disorder—Doxorubicin—testicular cancer	0.000138	0.000625	CcSEcCtD
Furosemide—Thrombocytopenia—Doxorubicin—testicular cancer	0.000138	0.000624	CcSEcCtD
Furosemide—Skin disorder—Doxorubicin—testicular cancer	0.000137	0.000619	CcSEcCtD
Furosemide—Paraesthesia—Epirubicin—testicular cancer	0.000137	0.000618	CcSEcCtD
Furosemide—Hyperhidrosis—Doxorubicin—testicular cancer	0.000136	0.000616	CcSEcCtD
Furosemide—Somnolence—Epirubicin—testicular cancer	0.000136	0.000612	CcSEcCtD
Furosemide—Anorexia—Doxorubicin—testicular cancer	0.000135	0.000607	CcSEcCtD
Furosemide—Feeling abnormal—Methotrexate—testicular cancer	0.000134	0.000606	CcSEcCtD
Furosemide—Gastrointestinal pain—Methotrexate—testicular cancer	0.000133	0.000602	CcSEcCtD
Furosemide—Decreased appetite—Epirubicin—testicular cancer	0.000133	0.000599	CcSEcCtD
Furosemide—Hypotension—Doxorubicin—testicular cancer	0.000132	0.000595	CcSEcCtD
Furosemide—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000132	0.000595	CcSEcCtD
Furosemide—Fatigue—Epirubicin—testicular cancer	0.000132	0.000594	CcSEcCtD
Furosemide—Constipation—Epirubicin—testicular cancer	0.00013	0.000589	CcSEcCtD
Furosemide—Pain—Epirubicin—testicular cancer	0.00013	0.000589	CcSEcCtD
Furosemide—Urticaria—Methotrexate—testicular cancer	0.00013	0.000585	CcSEcCtD
Furosemide—Abdominal pain—Methotrexate—testicular cancer	0.000129	0.000582	CcSEcCtD
Furosemide—Body temperature increased—Methotrexate—testicular cancer	0.000129	0.000582	CcSEcCtD
Furosemide—Paraesthesia—Doxorubicin—testicular cancer	0.000127	0.000572	CcSEcCtD
Furosemide—Feeling abnormal—Epirubicin—testicular cancer	0.000126	0.000568	CcSEcCtD
Furosemide—Somnolence—Doxorubicin—testicular cancer	0.000126	0.000567	CcSEcCtD
Furosemide—Gastrointestinal pain—Epirubicin—testicular cancer	0.000125	0.000563	CcSEcCtD
Furosemide—Decreased appetite—Doxorubicin—testicular cancer	0.000123	0.000554	CcSEcCtD
Furosemide—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000122	0.00055	CcSEcCtD
Furosemide—Fatigue—Doxorubicin—testicular cancer	0.000122	0.000549	CcSEcCtD
Furosemide—Urticaria—Epirubicin—testicular cancer	0.000121	0.000547	CcSEcCtD
Furosemide—Constipation—Doxorubicin—testicular cancer	0.000121	0.000545	CcSEcCtD
Furosemide—Pain—Doxorubicin—testicular cancer	0.000121	0.000545	CcSEcCtD
Furosemide—Abdominal pain—Epirubicin—testicular cancer	0.000121	0.000544	CcSEcCtD
Furosemide—Body temperature increased—Epirubicin—testicular cancer	0.000121	0.000544	CcSEcCtD
Furosemide—Hypersensitivity—Methotrexate—testicular cancer	0.00012	0.000542	CcSEcCtD
Furosemide—Asthenia—Methotrexate—testicular cancer	0.000117	0.000528	CcSEcCtD
Furosemide—Feeling abnormal—Doxorubicin—testicular cancer	0.000116	0.000525	CcSEcCtD
Furosemide—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000115	0.000521	CcSEcCtD
Furosemide—Pruritus—Methotrexate—testicular cancer	0.000115	0.000521	CcSEcCtD
Furosemide—Hypersensitivity—Epirubicin—testicular cancer	0.000112	0.000507	CcSEcCtD
Furosemide—Urticaria—Doxorubicin—testicular cancer	0.000112	0.000506	CcSEcCtD
Furosemide—Abdominal pain—Doxorubicin—testicular cancer	0.000112	0.000504	CcSEcCtD
Furosemide—Body temperature increased—Doxorubicin—testicular cancer	0.000112	0.000504	CcSEcCtD
Furosemide—Diarrhoea—Methotrexate—testicular cancer	0.000112	0.000504	CcSEcCtD
Furosemide—Asthenia—Epirubicin—testicular cancer	0.000109	0.000494	CcSEcCtD
Furosemide—Pruritus—Epirubicin—testicular cancer	0.000108	0.000487	CcSEcCtD
Furosemide—Dizziness—Methotrexate—testicular cancer	0.000108	0.000487	CcSEcCtD
Furosemide—Diarrhoea—Epirubicin—testicular cancer	0.000104	0.000471	CcSEcCtD
Furosemide—Hypersensitivity—Doxorubicin—testicular cancer	0.000104	0.00047	CcSEcCtD
Furosemide—Vomiting—Methotrexate—testicular cancer	0.000104	0.000468	CcSEcCtD
Furosemide—Rash—Methotrexate—testicular cancer	0.000103	0.000464	CcSEcCtD
Furosemide—Dermatitis—Methotrexate—testicular cancer	0.000103	0.000464	CcSEcCtD
Furosemide—Headache—Methotrexate—testicular cancer	0.000102	0.000461	CcSEcCtD
Furosemide—Asthenia—Doxorubicin—testicular cancer	0.000101	0.000457	CcSEcCtD
Furosemide—Dizziness—Epirubicin—testicular cancer	0.000101	0.000455	CcSEcCtD
Furosemide—Pruritus—Doxorubicin—testicular cancer	9.99e-05	0.000451	CcSEcCtD
Furosemide—Vomiting—Epirubicin—testicular cancer	9.7e-05	0.000438	CcSEcCtD
Furosemide—Nausea—Methotrexate—testicular cancer	9.68e-05	0.000437	CcSEcCtD
Furosemide—Diarrhoea—Doxorubicin—testicular cancer	9.66e-05	0.000436	CcSEcCtD
Furosemide—Rash—Epirubicin—testicular cancer	9.62e-05	0.000434	CcSEcCtD
Furosemide—Dermatitis—Epirubicin—testicular cancer	9.61e-05	0.000434	CcSEcCtD
Furosemide—Headache—Epirubicin—testicular cancer	9.56e-05	0.000431	CcSEcCtD
Furosemide—Dizziness—Doxorubicin—testicular cancer	9.34e-05	0.000421	CcSEcCtD
Furosemide—Nausea—Epirubicin—testicular cancer	9.06e-05	0.000409	CcSEcCtD
Furosemide—Vomiting—Doxorubicin—testicular cancer	8.98e-05	0.000405	CcSEcCtD
Furosemide—Rash—Doxorubicin—testicular cancer	8.9e-05	0.000402	CcSEcCtD
Furosemide—Dermatitis—Doxorubicin—testicular cancer	8.89e-05	0.000401	CcSEcCtD
Furosemide—Headache—Doxorubicin—testicular cancer	8.84e-05	0.000399	CcSEcCtD
Furosemide—Nausea—Doxorubicin—testicular cancer	8.39e-05	0.000379	CcSEcCtD
